RJF

RJF Change in Working Capital

-$1.42BTTM · USD

Period ending:

RJF FY Change in Working CapitalUSD
RJF FY Change in Working Capital1989-09-30: $65.30M1990-09-30: $15.40M1991-09-30: $25.70M1992-09-30: -$119.30M1993-09-30: -$37.60M1994-09-30: $173.50M1995-09-30: $201.50M1996-09-30: $318.80M1997-09-30: $196.20M1998-09-30: $348.70M1999-09-30: $156.00M2000-09-30: -$229.75M2001-09-30: $98.69M2002-09-30: -$91.24M2003-09-30: -$58.88M2004-09-30: -$286.33M2005-09-30: $197.62M2006-09-30: -$315.06M2007-09-30: $104.20M2008-09-30: -$275.08M2009-09-30: $12.61M2010-09-30: -$1.47B2011-09-30: $1.27B2012-09-30: -$12.23M2013-09-30: $155.66M2014-09-30: -$116.49M2015-09-30: $315.28M2016-09-30: -$1.11B2017-09-30: -$1.03B2018-09-30: -$253.00M2019-09-30: -$823.00M2020-09-30: $2.68B2021-09-30: $5.01B2022-09-30: -$2.15B2023-09-30: -$5.77B2024-09-30: $4.00M2025-09-30: $95.00M$5.01B-$5.77B
1989-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RJF change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 37 observations from Sep 30, 1989 to Sep 30, 2025.

Raymond James Financial Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
95,000,000
4,000,000
-5,773,000,000
-2,148,000,000
5,011,000,000
2,684,000,000
-823,000,000
-253,000,000
-1,031,000,000
-1,108,063,000
315,275,000
-116,492,000
155,660,000
-12,230,000
1,266,060,000
-1,473,056,000
12,613,000
-275,075,000
104,203,000
-315,058,000
197,621,000
-286,332,000
-58,881,000
-91,238,000
98,692,000
-229,749,000
156,000,000
348,700,000
196,200,000
318,800,000
201,500,000
173,500,000
-37,600,000
-119,300,000
25,700,000
15,400,000
65,300,000

Compare change in working capital

All RJF financial metrics · RJF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.